Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis

J Infect. 2022 Jun;84(6):e133-e136. doi: 10.1016/j.jinf.2022.02.012. Epub 2022 Feb 17.

Authors

Aamir Saeed¹, Basharat Ahmad¹, Sidra Majaz¹, Faisal Nouroz¹, Ashfaq Ahmad², Yingqiu Xie³

Affiliations

¹ Department of Bioinformatics, Hazara University, Mansehra 21300, Pakistan.
² Department of Bioinformatics, Hazara University, Mansehra 21300, Pakistan. Electronic address: ashfaq.binfo@hu.edu.pk.
³ Biology Department, Nazarbayev University, Nur-Sultan 010000, Kazakhstan. Electronic address: yingqiu.xie@nu.edu.kz.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Computer Simulation
Humans
Molecular Docking Simulation
Peptide Hydrolases
Protease Inhibitors / pharmacology
Protease Inhibitors / therapeutic use
SARS-CoV-2*

Substances

Protease Inhibitors
Peptide Hydrolases